In the present study, we determined the levels of serum FGF23 in a group of nondialyzed patients with CKD stages 3 and 4 subjected to elective femoral endarterectomy due to established clinical PAD and studied its correlation with different inflammatory markers. This evidence concerns the gene FGF23 and peripheral arterial disease.